<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Tocilizumab</italic>, a humanized anti‐human IL‐6 receptor monoclonal antibody, has been used for rheumatoid arthritis and other collagen diseases. Its effectiveness against COVID‐19 has been reported in China. A single‐arm study showed of a higher survival rate for patients with severe pneumonia.
 <xref rid="jog14384-bib-0048" ref-type="ref">
  <sup>48</sup>
 </xref>
</p>
